{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:22Z","timestamp":1786119442341,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1097\/inf.0b013e3181d73322","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T05:38:32Z","timestamp":1268890712000},"page":"310-313","source":"Crossref","is-referenced-by-count":38,"title":["Continuing Impact of Infectious Diseases on Childhood Deaths in England and Wales, 2003\u20132005"],"prefix":"10.1097","volume":"29","author":[{"given":"Shamez","family":"Ladhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Pebody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa L.","family":"Lamagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan P.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Sharland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210202","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/pubmed\/fdm009","article-title":"Income inequality and child mortality in wealthy nations.","volume":"29","author":"Collison","year":"2007","journal-title":"J Public Health (Oxf)"},{"key":"R2-7-20210202","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1001\/jama.298.18.2155","article-title":"Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States.","volume":"298","author":"Roush","year":"2007","journal-title":"JAMA"},{"key":"R3-7-20210202","article-title":"Why Children Die: A Pilot Study 2006; England (South West, North East and West Midlands), Wales and Northern Ireland.","year":"2008"},{"key":"R5-7-20210202","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/oxfordjournals.pubmed.a024463","article-title":"Inaccuracy in death certification\u2014where are we now?","volume":"18","author":"Maudsley","year":"1996","journal-title":"J Public Health Med"},{"key":"R6-7-20210202","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2105\/AJPH.79.10.1349","article-title":"Problems in measurement of accuracy of cause-of-death statistics.","volume":"79","author":"Moriyama","year":"1989","journal-title":"Am J Public Health"},{"key":"R7-7-20210202","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/S0950268806006625","article-title":"Modelling the unidentified mortality burden from thirteen infectious pathogenic microorganisms in infants.","volume":"135","author":"Markov","year":"2007","journal-title":"Epidemiol Infect"},{"key":"R8-7-20210202","article-title":"National Confidential Study of Deaths Following Meticillin-Resistant Staphylococcus aureus Infection.","year":"2007"},{"key":"R9-7-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1057\/hsq.2009.4","article-title":"Death certification following MRSA bacteraemia, England, 2004\u201305.","author":"Wheller","year":"2009","journal-title":"Health Stat Q"},{"key":"R10-7-20210202","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3201\/eid1508.090264","article-title":"Predictors of mortality following severe Streptococcus pyogenes infection.","volume":"15","author":"Lamagni","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"R11-7-20210202","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/S0140-6736(08)60798-9","article-title":"Infection and sudden unexpected death in infancy: a systematic retrospective case review.","volume":"371","author":"Weber","year":"2008","journal-title":"Lancet"},{"key":"R12-7-20210202","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0140-6736(08)61296-9","article-title":"Bacterial toxins and sudden unexpected death in infancy.","volume":"372","author":"Blackwell","year":"2008","journal-title":"Lancet"},{"key":"R13-7-20210202","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJMoa054869","article-title":"The under-recognized burden of influenza in young children.","volume":"355","author":"Poehling","year":"2006","journal-title":"N Engl J Med"},{"key":"R14-7-20210202","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1542\/peds.2007-3304","article-title":"Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003\u20132004 and 2004\u20132005 influenza seasons.","volume":"122","author":"Eisenberg","year":"2008","journal-title":"Pediatrics"},{"key":"R15-7-20210202","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/adc.2005.080028","article-title":"Should universal hepatitis B immunisation be introduced in the UK?","volume":"91","author":"English","year":"2006","journal-title":"Arch Dis Child"},{"key":"R16-7-20210202","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1086\/503433","article-title":"Long-term protection against carriage of hepatitis B virus after infant vaccination.","volume":"193","author":"van der Sande","year":"2006","journal-title":"J Infect Dis"},{"key":"R17-7-20210202","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0140-6736(08)60524-3","article-title":"Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.","volume":"371","author":"Linhares","year":"2008","journal-title":"Lancet"},{"key":"R18-7-20210202","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(07)61744-9","article-title":"Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study.","volume":"370","author":"Vesikari","year":"2007","journal-title":"Lancet"},{"key":"R19-7-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"key":"R20-7-20210202","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcv.2005.02.003","article-title":"Varicella vaccination of children in the United States: assessment after the first decade, 1995\u20132005.","volume":"33","author":"Grose","year":"2005","journal-title":"J Clin Virol"},{"key":"R21-7-20210202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.inf.0000148928.10057.86","article-title":"Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children.","volume":"24","author":"Pichichero","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R22-7-20210202","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":"Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R23-7-20210202","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.vaccine.2007.06.004","article-title":"Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults.","volume":"25","author":"Scott","year":"2007","journal-title":"Vaccine"},{"key":"R24-7-20210202","doi-asserted-by":"crossref","first-page":"10834","DOI":"10.1073\/pnas.0603940103","article-title":"A universal vaccine for serogroup B meningococcus.","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"R25-7-20210202","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/QCO.0b013e3283184245","article-title":"New strategies for control of respiratory syncytial virus infection.","volume":"21","author":"Nokes","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"R26-7-20210202","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/adc.2006.095760","article-title":"Childhood immunisation: what is the future?","volume":"92","author":"Pollard","year":"2007","journal-title":"Arch Dis Child"},{"key":"R27-7-20210202","first-page":"S365","article-title":"Mortality following invasive MRSA infection in England, 2004-5. In: Proceedings of the 17th European Congress of Clinical Microbiology and Infectious Diseases; March 31, 2007; Munich, Germany.","volume":"13","author":"Potz","year":"2007","journal-title":"Clin Microbiol Infect"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0b013e3181d73322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:16:04Z","timestamp":1786040164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201004000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181d73322","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}